Hemangioma Clinical Trial
Official title:
Treatment of Cutaneous Hemangioma of Infancy With Topical 0.5% Timolol Maleate Eye Drop Compared With Placebo in Pediatric Patients, Siriraj Hospital
Infantile hemangioma (IH) is the most common benign vascular tumor in pediatric population. The characteristic natural history of this tumor is rapid growth in the first year of life and follows by spontaneous involution. However, it may cause cosmetic unacceptable. Early intervention in superficial IH may help to minimize the risk of residual aesthetic problems. Topical timolol, a non selective beta-blocker, is an emerging treatment which has been reported in efficacy and safety for the treatment of IH. However, the reported studies were case-series or small study. This study is a prospective double-blind,randomized-controlled study to evaluate the efficacy and safety of 0.5% timolol maleate solution for treatment in superficial IH. The patient will be treated with topical timolol for at least 6 months and instructed to 4 times daily apply 1-2 drop of timolol solution on the lesion and rub over the entire lesion with a finger. Photographs of the lesion will be taken at the baseline and every 1-month visit. Clinical evaluation of the treatment efficacy is carried out by 2 investigators independently to determine the change in lesion size and visual analogue scale of the lesion color. The main outcome is to evaluate the efficacy of 0.5% timolol maleate solution in treatment of infantile hemangioma compared to placebo.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT00974129 -
A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
|
N/A | |
Completed |
NCT00374335 -
Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas
|
N/A | |
Recruiting |
NCT03331744 -
Clinical Characteristics of Infantile Hemangioma
|
||
Completed |
NCT02342275 -
Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
|
Phase 3 | |
Completed |
NCT00433940 -
Immune Suppression Of Infants Treated With Steroids
|
N/A | |
Completed |
NCT04065217 -
The Effectiveness of Diode Laser 980-nm in Iraqi Face Hemangioma: a Randomized Within Patients Trial
|
N/A | |
Terminated |
NCT01743885 -
Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma
|
Phase 3 | |
Terminated |
NCT00555464 -
Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas
|
Phase 2 | |
Completed |
NCT00394888 -
Hemangioma Associated With High Rates of Morbidity
|
N/A | |
Completed |
NCT05327309 -
Role of Propranolol as Compared to Bleomycin in Management of Hemangioma
|
N/A | |
Completed |
NCT02145884 -
Topical Timolol Gel for the Treatment of Infantile Hemangiomas
|
Phase 2 | |
Completed |
NCT04077515 -
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
|
Phase 4 | |
Completed |
NCT02731287 -
Topical Timolol for Infantile Hemangioma in Early Proliferative Phase
|
Phase 2 | |
Recruiting |
NCT01147601 -
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
|
Phase 0 | |
Completed |
NCT01908972 -
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma
|
Phase 4 | |
Completed |
NCT00540566 -
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
|
||
Completed |
NCT00001417 -
Direct Injection of Alcohol for the Treatment of Spinal Tumors
|
N/A | |
Completed |
NCT00004436 -
Randomized Study of Hormonal Regulation of Infantile Hemangioma
|
N/A | |
Recruiting |
NCT02496013 -
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
|
Phase 1 | |
Completed |
NCT01072045 -
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
|
Phase 2 |